- Home
- SBFM vs CMND Comparison
SBFM vs CMND Comparison
Compare SBFM & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- CMND
- Stock Information
- Founded
- SBFM 2006
- CMND 2017
- Country
- SBFM United States
- CMND Canada
- Employees
- SBFM N/A
- CMND N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- CMND Health Care
- Exchange
- SBFM Nasdaq
- CMND Nasdaq
- Market Cap
- SBFM 6.5M
- CMND 5.3M
- IPO Year
- SBFM N/A
- CMND N/A
- Fundamental
- Price
- SBFM $1.40
- CMND $1.03
- Analyst Decision
- SBFM Strong Buy
- CMND
- Analyst Count
- SBFM 1
- CMND 0
- Target Price
- SBFM $15.00
- CMND N/A
- AVG Volume (30 Days)
- SBFM 41.6K
- CMND 67.3K
- Earning Date
- SBFM 08-12-2025
- CMND 09-15-2025
- Dividend Yield
- SBFM N/A
- CMND N/A
- EPS Growth
- SBFM N/A
- CMND N/A
- EPS
- SBFM N/A
- CMND N/A
- Revenue
- SBFM $36,341,741.00
- CMND N/A
- Revenue This Year
- SBFM $32.20
- CMND N/A
- Revenue Next Year
- SBFM $32.74
- CMND N/A
- P/E Ratio
- SBFM N/A
- CMND N/A
- Revenue Growth
- SBFM 19.22
- CMND N/A
- 52 Week Low
- SBFM $1.17
- CMND $0.80
- 52 Week High
- SBFM $3.90
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- SBFM 41.45
- CMND 54.80
- Support Level
- SBFM $1.36
- CMND $0.96
- Resistance Level
- SBFM $1.52
- CMND $1.05
- Average True Range (ATR)
- SBFM 0.07
- CMND 0.05
- MACD
- SBFM -0.00
- CMND -0.00
- Stochastic Oscillator
- SBFM 25.00
- CMND 80.00
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.